Literature DB >> 19034668

M- and T-tropic HIVs promote apoptosis in rat neurons.

Alessia Bachis1, Francesca Biggio, Eugene O Major, Italo Mocchetti.   

Abstract

Neuronal loss, reactive astrocytes, and other abnormalities are seen in the brain of individuals with acquired immune deficiency syndrome-associated Dementia Complex (ADC). Human immunodeficiency virus-1 (HIV-1) is believed to be the main agent causing ADC. However, little is known about the molecular and cellular mechanisms of HIV-1 neurotoxicity considering that HIV-1 does not infect post-mitotic neurons and that viral load does not necessarily correlate with ADC. Various viral proteins, such as the envelope protein gp120 and the transcription activator Tat, have been shown to induce neuronal apoptosis through direct and indirect mechanisms both in vitro and in vivo. Progeny HIV-1 virions can also cause neuronal death. However, it has not been fully established yet whether HIV-1 promotes neuronal apoptosis by a direct mechanism. To explore the neurotoxic effect of HIV-1, we exposed rat cerebellar granule cells and cortical neurons in culture to two different strains of HIV-1, IIIB and BaL, T- and M-tropic strains that utilize CXCR4 and CCR5 coreceptors, respectively, to infect cells. We observed that both viruses elicit a time-dependent apoptotic cell death in these cultures without inducing a productive infection as determined by the absence of the core protein of HIV-1, p24, in cell lysates. Instead, neurons were gp120 positive, suggesting that the envelope protein is shed by the virus and then subsequently internalized by neurons. The CXCR4 receptor antagonist AMD3100 or the CCR5 receptor inhibitor D-Ala-peptide T-amide blocked HIV IIIB and HIV Bal neurotoxicity, respectively. In contrast, the N-methyl-D-aspartate receptor blocker MK801 failed to protect neurons from HIV-mediated apoptosis, suggesting that HIV-1 neurotoxicity can be initiated by the viral protein gp120 binding to neuronal chemokine receptors.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19034668      PMCID: PMC2683632          DOI: 10.1007/s11481-008-9141-3

Source DB:  PubMed          Journal:  J Neuroimmune Pharmacol        ISSN: 1557-1890            Impact factor:   4.147


  71 in total

1.  Use of laser capture microdissection to detect integrated HIV-1 DNA in macrophages and astrocytes from autopsy brain tissues.

Authors:  Melissa J Churchill; Paul R Gorry; Daniel Cowley; Luxshimi Lal; Secondo Sonza; Damian F J Purcell; Katherine A Thompson; Dana Gabuzda; Justin C McArthur; Carlos A Pardo; Steven L Wesselingh
Journal:  J Neurovirol       Date:  2006-04       Impact factor: 2.643

2.  Axonal transport of human immunodeficiency virus type 1 envelope protein glycoprotein 120 is found in association with neuronal apoptosis.

Authors:  Alessia Bachis; Sadia A Aden; Rachel L Nosheny; Peter M Andrews; Italo Mocchetti
Journal:  J Neurosci       Date:  2006-06-21       Impact factor: 6.167

3.  Neuroanatomical distribution of CXCR4 in adult rat brain and its localization in cholinergic and dopaminergic neurons.

Authors:  Ghazal Banisadr; Philippe Fontanges; France Haour; Patrick Kitabgi; William Rostène; Stéphane Mélik Parsadaniantz
Journal:  Eur J Neurosci       Date:  2002-11       Impact factor: 3.386

4.  Caspase cascades in human immunodeficiency virus-associated neurodegeneration.

Authors:  Gwenn A Garden; Samantha L Budd; Elena Tsai; Lisa Hanson; Marcus Kaul; Danielle M D'Emilia; Robert M Friedlander; Junying Yuan; Eliezer Masliah; Stuart A Lipton
Journal:  J Neurosci       Date:  2002-05-15       Impact factor: 6.167

Review 5.  Experimental and potential future therapeutic approaches for HIV-1 associated dementia targeting receptors for chemokines, glutamate and erythropoietin.

Authors:  M Kaul; S A Lipton
Journal:  Neurotox Res       Date:  2005-10       Impact factor: 3.911

Review 6.  The AIDS dementia complex: clinical and basic neuroscience with implications for novel molecular therapies.

Authors:  B A Navia; K Rostasy
Journal:  Neurotox Res       Date:  2005-10       Impact factor: 3.911

Review 7.  Brain-derived neurotrophic factor as a prototype neuroprotective factor against HIV-1-associated neuronal degeneration.

Authors:  R L Nosheny; I Mocchetti; A Bachis
Journal:  Neurotox Res       Date:  2005-10       Impact factor: 3.911

8.  Spatially distinct and functionally independent mechanisms of axonal degeneration in a model of HIV-associated sensory neuropathy.

Authors:  Giorgia Melli; Sanjay C Keswani; Angela Fischer; Weiran Chen; Ahmet Höke
Journal:  Brain       Date:  2006-03-14       Impact factor: 13.501

9.  HIV-tat induces formation of an LRP-PSD-95- NMDAR-nNOS complex that promotes apoptosis in neurons and astrocytes.

Authors:  Eliseo A Eugenin; Jessie E King; Avindra Nath; Tina M Calderon; R Suzanne Zukin; Michael V L Bennett; Joan W Berman
Journal:  Proc Natl Acad Sci U S A       Date:  2007-02-21       Impact factor: 11.205

Review 10.  Role of the alpha-chemokine stromal cell-derived factor (SDF-1) in the developing and mature central nervous system.

Authors:  Françoise Lazarini; To Nam Tham; Philippe Casanova; Fernando Arenzana-Seisdedos; Monique Dubois-Dalcq
Journal:  Glia       Date:  2003-04-15       Impact factor: 7.452

View more
  27 in total

Review 1.  Drug discovery research targeting the CXC chemokine receptor 4 (CXCR4).

Authors:  Won-Tak Choi; Srinivas Duggineni; Yan Xu; Ziwei Huang; Jing An
Journal:  J Med Chem       Date:  2011-12-02       Impact factor: 7.446

Review 2.  HIV-1 gp120 and drugs of abuse: interactions in the central nervous system.

Authors:  Peter S Silverstein; Ankit Shah; James Weemhoff; Santosh Kumar; D P Singh; Anil Kumar
Journal:  Curr HIV Res       Date:  2012-07       Impact factor: 1.581

3.  M-tropic HIV envelope protein gp120 exhibits a different neuropathological profile than T-tropic gp120 in rat striatum.

Authors:  Alessia Bachis; Maria I Cruz; Italo Mocchetti
Journal:  Eur J Neurosci       Date:  2010-07-28       Impact factor: 3.386

4.  Pharmacological induction of CCL5 in vivo prevents gp120-mediated neuronal injury.

Authors:  Lee A Campbell; Valeriya Avdoshina; Chris Day; Seung T Lim; Italo Mocchetti
Journal:  Neuropharmacology       Date:  2015-01-23       Impact factor: 5.250

5.  Synthesis of pyridine derivatives as potential antagonists of chemokine receptor type 4.

Authors:  Suazette Reid Mooring; Theresa Gaines; Zhongxing Liang; Hyunsuk Shim
Journal:  Heterocycl Comm       Date:  2014-05       Impact factor: 1.120

6.  Morphine induces the release of CCL5 from astrocytes: potential neuroprotective mechanism against the HIV protein gp120.

Authors:  Valeriya Avdoshina; Francesca Biggio; Guillermo Palchik; Lee A Campbell; Italo Mocchetti
Journal:  Glia       Date:  2010-10       Impact factor: 7.452

7.  PTEN gene silencing prevents HIV-1 gp120(IIIB)-induced degeneration of striatal neurons.

Authors:  Shiping Zou; Nazira El-Hage; Elizabeth M Podhaizer; Pamela E Knapp; Kurt F Hauser
Journal:  J Neurovirol       Date:  2011-01-14       Impact factor: 2.643

8.  HIV-1 gp120 Upregulates Brain-Derived Neurotrophic Factor (BDNF) Expression in BV2 Cells via the Wnt/β-Catenin Signaling Pathway.

Authors:  Yongdi Wang; Jinxu Liao; Shao-Jun Tang; Jianhong Shu; Wenping Zhang
Journal:  J Mol Neurosci       Date:  2017-05-30       Impact factor: 3.444

9.  Effects of Tat proteins and Tat mutants of different human immunodeficiency virus type 1 clades on glial JC virus early and late gene transcription.

Authors:  Clayton A Wright; Jonas A Nance; Edward M Johnson
Journal:  J Gen Virol       Date:  2012-11-14       Impact factor: 3.891

Review 10.  CNS inflammation and macrophage/microglial biology associated with HIV-1 infection.

Authors:  Anjana Yadav; Ronald G Collman
Journal:  J Neuroimmune Pharmacol       Date:  2009-09-19       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.